Status: current, Defined. Date: 30-Sep 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2536111000168116 | Rivastigmine (Apotex) (rivastigmine 1.5 mg) capsule (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2536121000168111 | Rivastigmine (Apotex) 1.5 mg capsule | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Rivastigmine (Apotex) 1.5 mg capsule | has manufactured dose form | capsule | true | Inferred relationship | Some | ||
| Rivastigmine (Apotex) 1.5 mg capsule | Is a | Rivastigmine (Apotex) | true | Inferred relationship | Some | ||
| Rivastigmine (Apotex) 1.5 mg capsule | Is a | rivastigmine 1.5 mg capsule | true | Inferred relationship | Some | ||
| Rivastigmine (Apotex) 1.5 mg capsule | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Rivastigmine (Apotex) 1.5 mg capsule | has manufactured dose form | hard capsule | false | Inferred relationship | Some | ||
| Rivastigmine (Apotex) 1.5 mg capsule | has unit of use | capsule | true | Inferred relationship | Some | 1068702205 | |
| Rivastigmine (Apotex) 1.5 mg capsule | has intended active ingredient | rivastigmine | true | Inferred relationship | Some | 1068702204 | |
| Rivastigmine (Apotex) 1.5 mg capsule | has Australian BoSS | rivastigmine | true | Inferred relationship | Some | 1068702204 |
Reference Sets
Trade product unit of use reference set
FHIR